Updated: Tue, 10/08/2024 - 20:06

On Wed, Oct. 9, campus is open to McGill students, employees and essential visitors. Most classes are in-person. See Campus Public Safety website for details.


Le mercredi 9 octobre, le campus est accessible aux étudiants et au personnel de l’Université, ainsi qu’aux visiteurs essentiels. La plupart des cours ont lieu en présentiel. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

Brain Tumour Program

About Brain Tumour 

A brain tumour is a growth of abnormal cells in the brain and can affect people of all ages. Not all brain tumors are malignant (cancerous), but even benign (noncancerous) tumours can impact brain function depending on their size and location.

An estimated 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. There are several treatment options for brain tumours.

Our Services

Brain Tumour program

Our Brain Tumour Program is one of the largest and most comprehensive research and treatment programs in the country. This includes the Brain Tumour Research Centre, the interdisciplinary Neuro-Oncology Clinic, the Neurosurgical Simulation and Artificial Intelligence Learning Centre, and collaboration with The Neuro’s Clinical Research Unit which develops clinical trials.

The clinic receives approximately 3,000 patient visits a year and provides the most advanced surgical and oncological treatments available. An interdisciplinary team of surgeons, nurses, oncologists, rehabilitation therapists and social workers is working to improve the care of individuals and families.

The program offers:

•Diagnostic tools and imaging, such as CT scan, PET scan and MRI

•Specialized surgeries

•Radiotherapy and chemotherapy treatments

• Access to clinical trials of promising new and safe treatments

•Full-time nursing care and social work

•Specialists for your spiritual and psychological needs

•Post-treatment care and rehabilitation with physiotherapists, occupational therapists, speech language therapists and nutritionists according to your needs

•Access to educational and support activities, such as the Network of hope, the Glioma Module, and the Neuro-Patient Resource Centre

 

Research

The Neuro is at the forefront of brain cancer research. In the past few years, our experts have made several revolutionary discoveries that have changed the course of brain cancer research worldwide. This includes promising drug targets that address brain cancer in its earliest stages, as well as pioneering new effective approaches to surgical treatment. 

The Neuro’s bench-to-bedside approach has made these developments possible: our patients provide cells that are analyzed, characterized and stored in our biobank; advanced stem-cell and organoid research allows us to adapt cells as needed to advance research and develop potential drug targets; and our clinical trials unit can test new treatments. We are home to the largest single cell RNA and DNA library in the world: a rich resource for identifying and testing promising new therapies.

Contact us

Room 203
Tel: 514- 398-5937
Fax: 514- 398-7195

Learn more about our Brain Tumour Program

your visit

research

resources

clinical trials

stories

Roberto Diaz, MD, PhD, FRCS(C)

Roberto Diaz, MD, PhD, FRCS(C)

Research areas: Brain Tumour
Jeffery Alan Hall, MD, FRCS(C)

Jeffery Alan Hall, MD, FRCS(C)

Research areas: Epilepsy
Kevin Petrecca, MD, PhD, FRCS(C)

Kevin Petrecca, MD, PhD, FRCS(C)

Research areas: Brain Tumour

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram x, formerly known as twitter linkedIn youtube

Back to top